The ascendancy of Viagra and its impact on the drug landscape presents a complicated question for investors. While the early sales figures were impressive, the exclusivity has expired, leading to a wave of copycat https://junaidorbt100753.blog2freedom.com/41488234/the-blue-pill-and-big-pharma-a-risky-bet